ARS Pharmaceuticals Announces Conference Call and Webcast on August 13 Outlining its Updated Strategic Priorities and Reporting Second Quarter 2026 Financial Results

Go back to ARS Pharmaceuticals Announces Conference Call and Webcast on August 13 Outlining its Updated Strategic Priorities and Reporting Second Quarter 2026 Financial Results
(NASDAQ: SPRY) Delayed: 4.20 -0.09 (2.1%)
Previous Close $4.29    52 Week High $ 
Open $4.32    52 Week Low $ 
Day High $4.42    P/E N/A 
Day Low $4.19    EPS $ 
Volume 634,816